The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs. (Q44288670)
scientific article published in January 2003
Language:
(P31) (Q13442814)
(P50) (Q56450442)
(Q88423750)
(P304) 505-512
(P407) (Q1860)
(P433) 2
(P478) 63
(P577) Wednesday, January 1, 2003
(P921) (Q101991)
(Q210861)
(P1433) (Q326097)
(P1476) "The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs" (language: en)
(P2093) Julian C Desmond
Joanne C Mountford
Mark T Drayson
Elizabeth A Walker
Jonathan P Ride
Quang T Luong
Rachel E Hayden
Elio F Vanin
other details
description scientific article published in January 2003

External Links